Prescription opioid use in Australian children and adolescents: a national population-based study
Field | Value | Language |
dc.contributor.author | Bell, Jane | |
dc.contributor.author | Pearson, Sallie-Anne | |
dc.contributor.author | Paget, Simon P | |
dc.contributor.author | Nielsen, Timothy | |
dc.contributor.author | Buckley, Nicholas A | |
dc.contributor.author | Collins, John | |
dc.contributor.author | Nassar, Natasha | |
dc.date.accessioned | 2019-12-10 | |
dc.date.available | 2019-12-10 | |
dc.date.issued | 2019-12-10 | |
dc.identifier.uri | https://hdl.handle.net/2123/21495 | |
dc.description.abstract | The increased use of strong opioids should be monitored as higher doses have been associated with increased opioid-related adverse events, (such as emergency department visits, hospital admissions and deaths) and opioid use in young populations is associated with future persistent use, non-medical use, and misuse | en_AU |
dc.language.iso | en_AU | en_AU |
dc.publisher | Elsevier | |
dc.rights | The final version of this paper was published in: The Lancet Child and Adolescent Health 2019; 3(12): 881-8. | |
dc.subject | opioid use | en_AU |
dc.subject | Australian children and adolescents | en_AU |
dc.title | Prescription opioid use in Australian children and adolescents: a national population-based study | en_AU |
dc.type | Article | en_AU |
dc.identifier.doi | 10.1016/S2352-4642(19)30329-3 | |
usyd.department | Menzies Centre for Health Policy | en_AU |
Associated file/s
Associated collections